about
Could gestational diabetes mellitus be managed through dietary bioactive compounds? Current knowledge and future perspectivesThe emerging role of epigenetics in cardiovascular diseaseThe potential of microRNAs in personalized medicine against cancers.MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review.Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic β- and α-Cells.MicroRNA-194 Modulates Glucose Metabolism and Its Skeletal Muscle Expression Is Reduced in DiabetesDisease, Models, Variants and Altered Pathways-Journeying RGD Through the Magnifying Glass.Development of Insulin Resistance through Induction of miRNA-135 in C2C12 CellsMicroRNAs and Cardiovascular Disease in Diabetes MellitusIRS-2 Partially Compensates for the Insulin Signal Defects in IRS-1-/- Mice Mediated by miR-33.miRNAs target databases: developmental methods and target identification techniques with functional annotations.Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease?MicroRNA-155: a Novel Armamentarium Against Inflammatory Diseases.Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia.Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome.microRNA-16 Is Downregulated During Insulin Resistance and Controls Skeletal Muscle Protein Accretion.The MicroRNA-21 signaling pathway is involved in prorenin receptor (PRR) -induced VEGF expression in ARPE-19 cells under a hyperglycemic condition.A dual discrimination mode for improved specificity towards let-7a detection via a single-base mutated padlock probe-based exponential rolling circle amplification.
P2860
Q26765972-19A948BC-FE2C-4412-86EE-5647C54F288EQ26852614-FAF9F1F6-285E-496D-AC82-E50C6E9CAC76Q34177547-62705DFE-93C4-4A76-8A8E-308CA9B3BBECQ34394249-4476BA89-BA1E-4CA2-8194-9A2D2A6E6046Q35925909-D1DD2DB0-5643-42C8-A7AB-6B5CE050B961Q36013285-FDEB881E-C35B-42CD-9FE3-851EF2B5D163Q36427543-C26C0CDD-E7FF-4452-9C08-FE787500DEA1Q37232019-8029786C-0E0F-4ACD-932D-28F10978C892Q37680890-C13BA567-95D4-4800-929D-4C47DA093C97Q37683511-B064BC50-4348-41C8-A40C-24DEDBB1FEFBQ38436885-298F2C6F-AC15-4A28-9232-3D515AB8E78BQ38481462-CEF28FDE-6D79-4C83-977B-1D1A293B01C7Q39040841-F751DCD6-A727-4621-8AF6-D682E747ADCFQ39568148-FEE207B6-A266-4915-842D-336237AE0061Q41014418-C9F54B05-CD53-4E1E-9682-DF15A5E046F7Q42127502-1C939F1F-6A7D-4AFB-A362-4B9E41156673Q42290908-A94DFFBD-4521-4FF3-A405-8291EA8A4AAFQ48161842-D45C964F-6CB8-4C86-8FAC-33CEF04C76C5
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
MicroRNAs as pharmacological targets in diabetes
@ast
MicroRNAs as pharmacological targets in diabetes
@en
MicroRNAs as pharmacological targets in diabetes
@nl
type
label
MicroRNAs as pharmacological targets in diabetes
@ast
MicroRNAs as pharmacological targets in diabetes
@en
MicroRNAs as pharmacological targets in diabetes
@nl
prefLabel
MicroRNAs as pharmacological targets in diabetes
@ast
MicroRNAs as pharmacological targets in diabetes
@en
MicroRNAs as pharmacological targets in diabetes
@nl
P2093
P2860
P3181
P1476
MicroRNAs as pharmacological targets in diabetes
@en
P2093
Ramkumar Mohan
Shungang Zhang
Xiaoqing Tang
Yiping Mao
P2860
P3181
P356
10.1016/J.PHRS.2013.06.005
P407
P577
2013-09-01T00:00:00Z